Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
Department of Medicine, University of Chicago, Chicago, Illinois.
J Clin Pharm Ther. 2019 Aug;44(4):579-587. doi: 10.1111/jcpt.12853. Epub 2019 Jun 1.
The use of generic oral contraceptives (OCPs) can improve adherence and reduce healthcare costs, yet scepticism of generic drugs remains a barrier to generic OCP discussion and prescription. An educational web module was developed to reduce generic scepticism related to OCPs, improve knowledge of generic drugs and increase physician willingness to discuss and prescribe generic OCPs.
A needs assessment was completed using in-person focus groups at American College of Physicians (ACP) Annual Meeting and a survey targeting baseline generic scepticism. Insights gained were used to build an educational web module detailing barriers and benefits of generic OCP prescription. The module was disseminated via email to an ACP research panel who completed our baseline survey. Post-module evaluation measured learner reaction, knowledge and intention to change behaviour along with generic scepticism.
The module had a response rate of 56% (n = 208/369). Individuals defined as generic sceptics at baseline were significantly less likely to complete our module compared to non-sceptics (responders 9.6% vs non-responders 16.8%, P = 0.04). The majority (85%, n = 17/20) of baseline sceptics were converted to non-sceptics (P < 0.01) following completion of the module. Compared to non-sceptics, post-module generic sceptics reported less willingness to discuss (sceptic 33.3% vs non-sceptic 71.5%, P < 0.01), but not less willingness to prescribe generic OCPs (sceptic 53.3% vs non-sceptic 67.9%, P = 0.25). Non-white physicians and international medical graduates (IMG) were more likely to be generic sceptics at baseline (non-white 86.9% vs white 69.9%, P = 0.01, IMG 13.0% vs USMG 5.0% vs unknown 18.2%, P = 0.03) but were also more likely to report intention to prescribe generic OCPs as a result of the module (non-white 78.7% vs white 57.3%, P < 0.01, IMG 76.1% vs USMG 50.3% vs unknown 77.3%, P = 0.03).
A brief educational web module can be used to promote prescribing of generic OCPs and reduce generic scepticism.
使用通用口服避孕药（OCP）可以提高依从性并降低医疗保健成本，但对仿制药的怀疑仍然是讨论和开通用 OCP 处方的障碍。开发了一个教育网络模块，以减少与 OCP 相关的通用药物怀疑，提高对仿制药的认识，并增加医生讨论和开通用 OCP 的意愿。
使用美国医师学院（ACP）年会的现场焦点小组和针对基线通用怀疑的调查完成需求评估。利用获得的见解构建了一个详细说明通用 OCP 处方的障碍和益处的教育网络模块。该模块通过电子邮件分发给 ACP 研究小组，他们完成了我们的基线调查。模块后的评估衡量了学习者的反应、知识和改变行为的意愿，以及通用怀疑。
该模块的回复率为 56%（n=208/369）。与非怀疑者相比，基线时被定义为通用怀疑者的人完成我们的模块的可能性明显降低（应答者 9.6%，而非应答者 16.8%，P=0.04）。完成模块后，大多数（85%，n=17/20）的基线怀疑者转变为非怀疑者（P<0.01）。与非怀疑者相比，模块后的通用怀疑者表示不太愿意讨论（怀疑者 33.3%，非怀疑者 71.5%，P<0.01），但不太愿意开通用 OCP（怀疑者 53.3%，非怀疑者 67.9%，P=0.25）。非白人医生和国际医学毕业生（IMG）在基线时更有可能成为通用怀疑者（非白人 86.9%，白人 69.9%，P=0.01，IMG 13.0%，美国医学毕业生 5.0%，未知 18.2%，P=0.03），但也更有可能报告由于模块而打算开通用 OCP（非白人 78.7%，白人 57.3%，P<0.01，IMG 76.1%，美国医学毕业生 50.3%，未知 77.3%，P=0.03）。
简短的教育网络模块可用于促进通用 OCP 的处方并减少通用怀疑。
